within Pharmacolibrary.Drugs.ATC.R;

model R03AL02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 0.38999999999999996,
    adminDuration  = 600,
    adminMass      = 0.0025,
    adminCount     = 1,
    Vd             = 0.156,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Fixed-dose combination of salbutamol (a short-acting beta2-adrenergic agonist) and ipratropium bromide (a short-acting muscarinic antagonist) used primarily as a bronchodilator in the management of chronic obstructive pulmonary disease (COPD) and sometimes asthma. The combination is approved and widely used today in inhalation formulations for rapid symptomatic relief.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult population, based on published PK data for separate components (inhaled salbutamol, inhaled ipratropium bromide); no published population PK studies available for the fixed combination product.</p><h4>References</h4><ol><li><p> (2020). Drugs for COPD. <i>The Medical letter on drugs and therapeutics</i> 62(1606) 137–144. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32960872/&quot;>https://pubmed.ncbi.nlm.nih.gov/32960872</a></p></li><li><p>MacGregor, TR, et al., &amp; Wood, CC (2016). Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler. <i>Clinical and translational science</i> 9(2) 105–113. DOI:<a href=&quot;https://doi.org/10.1111/cts.12387&quot;>10.1111/cts.12387</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26945929/&quot;>https://pubmed.ncbi.nlm.nih.gov/26945929</a></p></li><li><p>Wu, J, et al., &amp; Zhi, X (2011). Simultaneous determination of ipratropium and salbutamol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 879(30) 3475–3483. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2011.09.027&quot;>10.1016/j.jchromb.2011.09.027</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21983198/&quot;>https://pubmed.ncbi.nlm.nih.gov/21983198</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R03AL02;
